| Renal clearance of quantum dots | Nature Biotechnology | 2007 | 3.3K |
| EGFR mutation and resistance of non-small-cell lung cancer to gefitinib | New England Journal of Medicine | 2005 | 3.3K |
| Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping | Nature Biotechnology | 2004 | 1.8K |
| Integrative clinical genomics of advanced prostate cancer | Cell | 2015 | 1.8K |
| New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway | Proceedings of the National Academy of Sciences of the United States of America | 1999 | 1.7K |
| Extrapulmonary manifestations of COVID-19 | Nature Medicine | 2020 | 1.3K |
| Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma | Journal of Clinical Oncology | 2004 | 847 |
| Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice | Proceedings of the National Academy of Sciences of the United States of America | 1997 | 776 |
| Protein tyrosine phosphatases in signal transduction | Current Opinion in Cell Biology | 1997 | 709 |
| The idiopathic hypereosinophilic syndrome | Blood | 1994 | 693 |
| Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer | Cell | 2009 | 691 |
| Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway | New England Journal of Medicine | 2016 | 661 |
| Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling | Proceedings of the National Academy of Sciences of the United States of America | 2002 | 661 |
| Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released | Blood | 2008 | 648 |
| Design considerations for tumour-targeted nanoparticles | Nature Nanotechnology | 2010 | 633 |
| Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma | Journal of Clinical Oncology | 2005 | 624 |
| Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes | Nature | 1998 | 613 |
| The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein | Nature | 1999 | 606 |
| Function of WW domains as phosphoserine- or phosphothreonine-binding modules | Science | 1999 | 591 |
| EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent | Science | 2012 | 585 |
| The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping | Annals of Surgical Oncology | 2009 | 541 |
| Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA | Molecular Cell | 2003 | 540 |
| The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery | Journal of Surgical Oncology | 2011 | 539 |
| Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex | Nature | 2009 | 528 |
| The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease | Nature Reviews Molecular Cell Biology | 2007 | 521 |
